Nanomedicines: A Potential Treatment for Blood Disorder Diseases
Blood disorder diseases (BDDs), also known as hematologic, is one of the diseases owing to hematopoietic system disorder. Chemotherapy, bone marrow transplantation, and stem cells therapy have been used to treat BDDs. However, the cure rates are still low due to the availability of the right type of...
Main Authors: | Nan Zhang, Ming-Yuan Wei, Qiang Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fbioe.2019.00369/full |
Similar Items
-
Advancement of platelet-inspired nanomedicine
by: Shujun Wang, et al.
Published: (2018-10-01) -
Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders
by: Zi-Hua Guo, et al.
Published: (2023-01-01) -
Analysis of red blood cells supply before and after the outbreak of COVID-19 from 2018 to 2021 in 18 domestic blood centers
by: Dongyan ZHAO, et al.
Published: (2023-10-01) -
Advances in blood–brain barrier-crossing nanomedicine for anti-glioma
by: Dongdong Liu, et al.
Published: (2023-05-01) -
Recent progress of nanomedicine in the treatment of Alzheimer’s disease
by: Liqiang Hu, et al.
Published: (2023-06-01)